These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24126712)

  • 1. Determinants of left ventricular hypertrophy in patients with recent diagnosis of essential hypertension.
    Buono F; Crispo S; Pagano G; Rengo G; Petitto M; Grieco F; Trimarco B; Morisco C
    J Hypertens; 2014 Jan; 32(1):166-73. PubMed ID: 24126712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed essential hypertensives.
    Cuspidi C; Macca G; Sampieri L; Michev I; Fusi V; Salerno M; Severgnini B; Corti C; Magrini F; Zanchetti A
    J Hum Hypertens; 2001 Sep; 15(9):619-25. PubMed ID: 11550108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of combined target-organ damage in patients with essential hypertension.
    Carpinella G; Pagano G; Buono F; Petitto M; Guarino G; Orefice G; Rengo G; Trimarco B; Morisco C
    Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Zanchetti A
    J Hypertens; 2006 Aug; 24(8):1671-7. PubMed ID: 16877972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in cardiovascular risk profile by echocardiography in medium-risk elderly hypertensives.
    Cuspidi C; Michev L; Severgnini B; Meani S; Fusi V; Valerio C; Bertazzoli G; Magrini F; Zanchetti A
    J Hum Hypertens; 2003 Feb; 17(2):101-6. PubMed ID: 12574787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS).
    Cuspidi C; Mancia G; Ambrosioni E; Pessina A; Trimarco B; Zanchetti A;
    J Hum Hypertens; 2004 Dec; 18(12):891-6. PubMed ID: 15284833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
    J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy in nondiabetic predialysis CKD.
    Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
    Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity in adolescence is associated with left ventricular hypertrophy and hypertension.
    Movahed MR; Bates S; Strootman D; Sattur S
    Echocardiography; 2011 Feb; 28(2):150-3. PubMed ID: 21276070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.
    Cerasola G; Nardi E; Mulè G; Palermo A; Cusimano P; Guarneri M; Arsena R; Giammarresi G; Carola Foraci A; Cottone S
    Nephrology (Carlton); 2010 Mar; 15(2):203-10. PubMed ID: 20470280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study.
    de Simone G; Kizer JR; Chinali M; Roman MJ; Bella JN; Best LG; Lee ET; Devereux RB;
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):191-6. PubMed ID: 15752946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ambulatory arterial pressure and left ventricular hypertrophy in untreated hypertensive patients].
    Pascual JM; Baldó E; Bertolín V; Rovira E; Gonzalvo F; González C; Redon J
    Med Clin (Barc); 1999 Feb; 112(5):166-70. PubMed ID: 10091209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7).
    Cuspidi C; Giudici V; Negri F; Meani S; Sala C; Zanchetti A; Mancia G
    J Hypertens; 2009 Dec; 27(12):2465-71. PubMed ID: 19898252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age related prevalence of severe left ventricular hypertrophy in essential hypertension: echocardiographic findings from the ETODH study.
    Cuspidi C; Meani S; Sala C; Valerio C; Negri F; Mancia G
    Blood Press; 2012 Jun; 21(3):139-45. PubMed ID: 22416806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension.
    Anan F; Yonemochi H; Masaki T; Takahashi N; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Eshima N; Saikawa T; Yoshimatsu H
    Hypertens Res; 2007 Feb; 30(2):125-31. PubMed ID: 17460382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sex differences in the correlation between obesity and hypertension with left ventricular mass and hypertrophy].
    Kuch B; Muscholl M; Luchner A; Döring A; Riegger GA; Schunkert H; Hense HW
    Z Kardiol; 1996 May; 85(5):334-42. PubMed ID: 8711946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.
    van den Hoogen JP; van Kruijsdijk MC; van Ree JW; Mokkink HG; Thien T; van Weel C
    J Hum Hypertens; 1993 Oct; 7(5):473-7. PubMed ID: 8263888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors in Thai elderly men and women.
    Chantra S; Bhuthong B
    J Med Assoc Thai; 2000 Sep; 83(9):1082-94. PubMed ID: 11075977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.